Long-Term Natural Course of Pathologic Myopia in Chinese Patients Post date November 16, 2022 ← Myopia and orthokeratology for myopia control → Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control
